ACSL1 and obesity disorder: Downregulation of ACSL1 enhances insulin sensitivity and glucose uptake by reducing long-chain acyl-CoA (LCA-CoA), ceramide (Cer), and diacylglycerol (DAG) levels, thereby alleviating obesity [93].